SLC2A3 and head and neck squamous cell carcinoma: A worse prognosis was observed in patients with HNSCC who exhibited high levels of expression of SEC11A, SC5D, CYB5B, HPRT1, and SLC2A3 and low levels of expression of CORO1A and PIK3R3.